About: Comparison of Respiratory Pathogen Detection in Upper versus Lower Respiratory Tract Samples Using the BioFire FilmArray Respiratory Panel in the Immunocompromised Host

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Comparison of Respiratory Pathogen Detection in Upper versus Lower Respiratory Tract Samples Using the BioFire FilmArray Respiratory Panel in the Immunocompromised Host Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Comparison of Respiratory Pathogen Detection in Upper versus Lower Respiratory Tract Samples Using the BioFire FilmArray Respiratory Panel in the Immunocompromised Host
Creator	Azadeh, Natalya Saeed, Ali Binnicker, Matthew Grys, Thomas Limper, Andrew Mullon, John Sakata, Kenneth
topic	covid:1697f41650571796c51a52e8f5412d293f620c79#this
Source	PMC
abstract	BACKGROUND: The FilmArray Respiratory Panel (FARP) (BioFire Diagnostics, Inc.) is a multiplex, polymerase chain reaction (PCR) technique that can detect 17 respiratory viruses and 3 bacterial targets in a single reaction. Immunocompromised hosts (ICH) with respiratory illnesses often undergo bronchoscopy with bronchoalveolar lavage (BAL). This prospective study aimed to evaluate the yield and concordance of NP and BAL FARP testing when performed on the same patient concurrently. METHODS: From February to December 2016, 125 patients (100 ICH and 25 non-ICH) were enrolled. NP swabs and BAL samples were sent for FARP testing. RESULTS: The yield of the BAL FARP among ICH and non-ICH was 24% (24/100) and 8% (2/25), respectively. The yield of positive NP swabs in ICH was 27% (27/100) versus 4% (1/25) in non-ICH. The majority of patients (89%; 111/125) had concordant results between NP and BAL specimens. Of the 24 ICH patients who had a positive BAL FARP, the majority (79%) had the same pathogen detected from the NP swab. CONCLUSION: The FARP may be useful in the ICH. Given the high concordance, in patients whom a pathogen is identified on the NP FARP, a FARP performed on BAL will likely yield the same result. However, if the NP FARP is negative, performing the test on a BAL sample may have an incremental yield.
has issue date	2018-04-05(xsd:dateTime)
bibo:doi	10.1155/2018/2685723
bibo:pmid	29849830
has license	cc-by
sha1sum (hex)	1697f41650571796c51a52e8f5412d293f620c79
schema:url	https://doi.org/10.1155/2018/2685723
resource representing a document's title	Comparison of Respiratory Pathogen Detection in Upper versus Lower Respiratory Tract Samples Using the BioFire FilmArray Respiratory Panel in the Immunocompromised Host
has PubMed Central identifier	PMC5907482
has PubMed identifier	29849830
schema:publication	Can Respir J
resource representing a document's body	covid:1697f41650571796c51a52e8f5412d293f620c79#body_text
is http://vocab.deri.ie/void#inDataset of	proxy:http/ns.inria.fr/covid19/1697f41650571796c51a52e8f5412d293f620c79
is schema:about of	named entity 'INC' named entity 'FEBRUARY' named entity 'TECHNIQUE' named entity 'PERFORMED' named entity 'IMMUNOCOMPROMISED' named entity 'BAL' named entity 'PATIENT' named entity 'DECEMBER' named entity 'MULTIPLEX' named entity 'EVALUATE' named entity 'December' named entity 'FARP' named entity 'concordance' named entity 'bronchoscopy' named entity 'Respiratory' named entity 'UPPER' covid:arg/1697f41650571796c51a52e8f5412d293f620c79 named entity 'HOSTS' named entity '125' named entity 'TESTING' named entity 'REACTION' named entity 'SENT' named entity 'DETECT' named entity 'SWABS' named entity 'NON-' named entity 'RESPIRATORY' named entity 'PATHOGEN DETECTION' named entity 'COMPARISON' named entity 'SAMPLES' named entity 'IMMUNOCOMPROMISED HOST' named entity 'USING' named entity 'PANEL' named entity 'LOWER RESPIRATORY TRACT' named entity 'ENROLLED' named entity 'BACTERIAL' named entity 'TARGETS' named entity '28100' named entity 'RESPIRATORY VIRUSES' named entity 'BACKGROUND' named entity 'FARP' named entity 'CONCORDANCE' named entity 'IS A' named entity 'ICH' named entity 'SAMPLES' named entity 'PATIENTS' named entity 'DIAGNOSTICS' named entity 'PANEL' named entity 'POLYMERASE CHAIN REACTION' named entity 'PROSPECTIVE STUDY' named entity 'ILLNESSES' named entity 'SINGLE' named entity 'YIELD' named entity 'METHODS' named entity 'RESPIRATORY' named entity 'BRONCHOSCOPY WITH BRONCHOALVEOLAR LAVAGE' named entity 'patient' named entity 'detect' named entity 'Respiratory' named entity 'Inc' named entity 'bronchoalveolar lavage' named entity 'ICH' named entity 'Immunocompromised' named entity 'PCR' named entity 'radiographic' named entity 'sedation' named entity 'bronchoalveolar lavage' named entity 'radiographic' named entity 'pathogen' named entity 'bronchoscopy' named entity 'viral pathogen' named entity 'mycobacterial' named entity 'pathogen' named entity 'institutional review board'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software